EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients

Christophe Camus, Mélanie Poinot, Charlotte Pronier, Michel Rayar, Anne Le Neillon, Marianne Latournerie, Gisèle Lagathu, Matthieu Revest iD

Transplant Infectious Disease · 2024

DOI: 10.1111/tid.14282 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Transplant Infectious Disease, 2024. Verfasst von Christophe Camus und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Intensive Care, University Hospital of Rennes, Rennes, France. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Liver Transplantation, Antiviral Agents, Cytomegalovirus. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Prophylaxis (P) or pre‐emptive strategy (PS) in high‐risk liver transplant recipients (LTRs) are either recommended. We compared the results of each strategy.

Methods

Two groups of LTR transplanted during two consecutive periods were compared. Only cytomegalovirus (CMV)‐mismatched LTR (Donor +/ Recipient ‐) were included. The primary endpoints were: the onset of polymerase chain reaction‐based DNAemia and the proportion of patients with CMV disease. A number of episodes of CMV infection, antiviral therapy, ganciclovir resistance, infectious or immunological complications, cost of both strategies, and survival (1, 5, and 10 years) were also compared.

Results

Forty‐eight and 60 patients were respectively included in the P and PS groups. Eighteen (38%) in the P group and 56 (93%) in the PS group had CMV DNAemia ( p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsLiver TransplantationAntiviral AgentsCytomegalovirusGanciclovirHumansMaleMiddle AgedFemaleAdultAgedTransplant RecipientsDNA, ViralGraft RejectionRetrospective StudiesDrug Resistance, Viral

Stichwörter der Autor:innen

cytomegalovirus infectionliver transplantationoutcomespreemptive strategyprophylactic strategy

Substanzen

Antiviral AgentsGanciclovirDNA, Viral

Autor:innen und Institutionen

  • Department of Infectious Diseases and Intensive Care, University Hospital of Rennes, Rennes, France.
  • CIC-INSERM 1414, University Hospital of Rennes and University of Rennes, Rennes, France.
  • Department of Virology, University hospital of Rennes, Rennes, France.
  • Department of liver transplantation, University Hospital of Rennes, Rennes, France.
  • Laboratory BIOLARIS, Laval, France.
  • Department of Hepatology, University Hospital of Dijon, Dijon, France.

ORCID-Profile: Matthieu Revest

Zitieren

APA

Camus, C., Poinot, M., Pronier, C., Rayar, M., Neillon, A. L., Latournerie, M., Lagathu, G., & Revest, M. (2024). Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients. Transplant Infectious Disease. https://doi.org/10.1111/tid.14282

Vancouver

Camus C, Poinot M, Pronier C, Rayar M, Neillon AL, Latournerie M, et al. Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients. Transplant Infectious Disease. 2024. doi:10.1111/tid.14282

BibTeX
@article{Camus2024,
  author = {Camus, Christophe and Poinot, Mélanie and Pronier, Charlotte and Rayar, Michel and Neillon, Anne Le and Latournerie, Marianne and Lagathu, Gisèle and Revest, Matthieu},
  title = {Comparison of prophylaxis and preemptive strategy as cytomegalovirus prevention in liver transplant recipients},
  journal = {Transplant Infectious Disease},
  year = {2024},
  doi = {10.1111/tid.14282}
}
Kostenlos starten →